NDC 72934-7058

CLOBETASOL PROPIONATE 0.05% / LEVOCETIRIZINE DIHYDROCHLORIDE 2%

Clobetasol Propionate 0.05% / Levocetirizine Dihydrochloride 2%

CLOBETASOL PROPIONATE 0.05% / LEVOCETIRIZINE DIHYDROCHLORIDE 2% is a Topical Shampoo in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Clobetasol Propionate; Levocetirizine Dihydrochloride.

Product ID72934-7058_8903ce74-bf79-1c4a-e053-2995a90a69f2
NDC72934-7058
Product TypeHuman Prescription Drug
Proprietary NameCLOBETASOL PROPIONATE 0.05% / LEVOCETIRIZINE DIHYDROCHLORIDE 2%
Generic NameClobetasol Propionate 0.05% / Levocetirizine Dihydrochloride 2%
Dosage FormShampoo
Route of AdministrationTOPICAL
Marketing Start Date2019-05-17
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameCLOBETASOL PROPIONATE; LEVOCETIRIZINE DIHYDROCHLORIDE
Active Ingredient Strength0 g/100g; g/100g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-7058-6

120 g in 1 BOTTLE, PLASTIC (72934-7058-6)
Marketing Start Date2019-05-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-7058-6 [72934705806]

CLOBETASOL PROPIONATE 0.05% / LEVOCETIRIZINE DIHYDROCHLORIDE 2% SHAMPOO
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-17

Drug Details

Active Ingredients

IngredientStrength
CLOBETASOL PROPIONATE.05 g/100g

OpenFDA Data

SPL SET ID:8903ce74-bf78-1c4a-e053-2995a90a69f2
Manufacturer
UNII

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Histamine H1 Receptor Antagonists [MoA]
  • Histamine-1 Receptor Antagonist [EPC]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Histamine H1 Receptor Antagonists [MoA]
  • Histamine-1 Receptor Antagonist [EPC]

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.